甘氨酰环素类：新一代四环素类药物。 - Suppr

Suppr

超能文献

Glycylcyclines: a new generation of tetracyclines.

作者信息

Tally F T, Ellestad G A, Testa R T

机构信息

Medical Research Division, American Cyanamid Company, Pearl River, New York 10965, USA.

出版信息

J Antimicrob Chemother. 1995 Apr;35(4):449-52. doi: 10.1093/jac/35.4.449.

DOI:10.1093/jac/35.4.449

PMID:7628979

Abstract

摘要

相似文献

Glycylcyclines: a new generation of tetracyclines.甘氨酰环素类：新一代四环素类药物。

J Antimicrob Chemother. 1995 Apr;35(4):449-52. doi: 10.1093/jac/35.4.449.

In vitro and in vivo antibacterial activities of the glycylcyclines, a new class of semisynthetic tetracyclines.新型半合成四环素类——甘氨酰环素的体外和体内抗菌活性

Antimicrob Agents Chemother. 1993 Nov;37(11):2270-7. doi: 10.1128/AAC.37.11.2270.

New developments in tetracycline antibiotics: glycylcyclines and tetracycline efflux pump inhibitors.四环素类抗生素的新进展：甘氨酰环素类和四环素外排泵抑制剂。

Drug Resist Updat. 2002 Jul-Aug;5(3-4):119-25. doi: 10.1016/s1368-7646(02)00051-1.

Mutations in the interdomain loop region of the tetA(A) tetracycline resistance gene increase efflux of minocycline and glycylcyclines.tetA(A) 四环素抗性基因的结构域间环区域突变会增加米诺环素和甘氨酰环素的外排。

Microb Drug Resist. 2000 Winter;6(4):277-82. doi: 10.1089/mdr.2000.6.277.

Inhibition of protein synthesis occurring on tetracycline-resistant, TetM-protected ribosomes by a novel class of tetracyclines, the glycylcyclines.一类新型四环素（甘氨酰环素）对在耐四环素、由TetM蛋白保护的核糖体上发生的蛋白质合成的抑制作用。

Antimicrob Agents Chemother. 1994 Jul;38(7):1658-60. doi: 10.1128/AAC.38.7.1658.

Glycylcyclines: third-generation tetracycline antibiotics.甘氨酰环素类：第三代四环素类抗生素。

Curr Opin Pharmacol. 2001 Oct;1(5):464-9. doi: 10.1016/s1471-4892(01)00081-9.

Part X. Tetracycline and glycylcycline antimicrobials.第十部分。四环素类和甘氨酰环素类抗菌药物。

J Okla State Med Assoc. 2007 Jun;100(6):241-7.

Activity of glycylcyclines CL 329998 and CL 331002 against minocycline-resistant and other strains of methicillin-resistant Staphylococcus aureus.甘氨环素CL 329998和CL 331002对米诺环素耐药及其他耐甲氧西林金黄色葡萄球菌菌株的活性。

J Antimicrob Chemother. 1996 Jun;37(6):1171-5. doi: 10.1093/jac/37.6.1171.

Reactualisation of the in vitro activity of tetracycline antibiotics.

Acta Clin Belg. 1988;43(6):437-48. doi: 10.1080/17843286.1988.11717972.

The glycylcyclines: a comparative review with the tetracyclines.甘氨酰环素类：与四环素类的比较性综述

Drugs. 2004;64(1):63-88. doi: 10.2165/00003495-200464010-00005.

引用本文的文献

Low levels of tetracyclines select for a mutation that prevents the evolution of high-level resistance to tigecycline.低浓度的四环素会选择出一种突变，从而阻止高水平的替加环素耐药性的进化。

PLoS Biol. 2022 Sep 28;20(9):e3001808. doi: 10.1371/journal.pbio.3001808. eCollection 2022 Sep.

Total synthesis of viridicatumtoxin B and analogues thereof: strategy evolution, structural revision, and biological evaluation.绿麦隆毒素B及其类似物的全合成：策略演变、结构修正及生物学评价。

J Am Chem Soc. 2014 Aug 27;136(34):12137-60. doi: 10.1021/ja506472u. Epub 2014 Aug 15.

Potential role of tigecycline in the treatment of community-acquired bacterial pneumonia.替加环素在治疗社区获得性细菌性肺炎中的潜在作用。

Infect Drug Resist. 2011;4:77-86. doi: 10.2147/IDR.S6030. Epub 2011 Mar 2.

Tigecycline in the treatment of complicated intra-abdominal and complicated skin and skin structure infections.替加环素治疗复杂性腹腔内感染和复杂性皮肤软组织感染。

Ther Clin Risk Manag. 2007 Dec;3(6):1059-70.

Presence of tetracycline resistance determinants and susceptibility to tigecycline and minocycline.四环素耐药决定因素的存在以及对替加环素和米诺环素的敏感性。

Antimicrob Agents Chemother. 2005 Apr;49(4):1636-8. doi: 10.1128/AAC.49.4.1636-1638.2005.

The glycylcyclines: a comparative review with the tetracyclines.甘氨酰环素类：与四环素类的比较性综述

Drugs. 2004;64(1):63-88. doi: 10.2165/00003495-200464010-00005.

Comparison of the in vitro activity of the glycylcycline tigecycline (formerly GAR-936) with those of tetracycline, minocycline, and doxycycline against isolates of nontuberculous mycobacteria.甘氨酰环素替加环素（原GAR-936）与四环素、米诺环素和多西环素对非结核分枝杆菌分离株的体外活性比较。

Antimicrob Agents Chemother. 2002 Oct;46(10):3164-7. doi: 10.1128/AAC.46.10.3164-3167.2002.

Vancomycin-resistant enterococci.耐万古霉素肠球菌

Clin Microbiol Rev. 2000 Oct;13(4):686-707. doi: 10.1128/CMR.13.4.686.

In vivo pharmacodynamic activities of two glycylcyclines (GAR-936 and WAY 152,288) against various gram-positive and gram-negative bacteria.两种甘氨酰环素（GAR-936和WAY 152,288）对多种革兰氏阳性菌和革兰氏阴性菌的体内药效学活性。

Antimicrob Agents Chemother. 2000 Apr;44(4):943-9. doi: 10.1128/AAC.44.4.943-949.2000.

Antibacterial agents that inhibit two-component signal transduction systems.抑制双组分信号转导系统的抗菌剂。

Proc Natl Acad Sci U S A. 1998 Apr 28;95(9):5317-22. doi: 10.1073/pnas.95.9.5317.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验